Substances inhibiting proteic adp ribosilation suitable to prevent the diabetes mellitus complications.

摘要

The present invention refers to the use of substances inhibiting proteic ADP-ribosilation and of their soluble salts and complexes as active substances for the preparation of pharmaceutical compositions suitable to prevent the diabetes mellitus complications as neuropathies, nephropathies, retinopathies, macroangiopathies, microangiopathies and hepatopathies.